Go Symbol Lookup
Loading...

Companies

More

  • J&J Tops Estimates on Newer Medicine Growth Tuesday, 16 Apr 2013 | 8:16 AM ET

    The pharmaceutical and medical devices company reported quarterly earnings and revenue Tuesday that exceeded Wall Street's expectations as growth of newer medicines for cancer, hepatitis C and blood clots offset declining sales of its treatments for heartburn and attention deficit disorder.

  • Dell Strikes Deal With Icahn to Stave Off Buyout Tuesday, 16 Apr 2013 | 8:07 AM ET
    Michael Dell

    Dell said that it had entered into an agreement with Carl Icahn to prevent the activist investor from accumulating any more than 10 percent of the Dell's stock.

  • *Gold recouped some of their earlier steep losses but remained volatile after investors dumped risk assets overnight, gripped by worries over slowing growth in China and the United States. *U.S.-listed shares of Barrick Gold rose 3.9 percent to $20.56 and Randgold Resources climbed 6.2 percent to $73.30 in premarket trade.

  • European shares slip for 3rd straight session Tuesday, 16 Apr 2013 | 4:25 AM ET

    PARIS, April 16- European shares slid early on Tuesday, retreating for the third consecutive session, mirroring a sharp sell-off in U.S. stocks and commodity prices as mounting worries over the pace of global growth rattle investors.

  • Micky's Mea Culpa: Arison to Refund US Taxpayers Monday, 15 Apr 2013 | 6:46 PM ET
    Mickey Arison, CEO Carnival Corp.

    Carnival CEO Micky Arison says Carnival plans to reimburse taxpayers for the cost of the Navy and Coast Guard's help with two of the company's high-profile incidents.

  • *FDA reviewers: Efficacy data not entirely consistent. Breo was developed by GlaxoSmithKline Plc, and Theravance Inc, whose shares jumped on Monday. GSK's shares rose 3.9 percent to 1,630 pence on the London Stock Exchange, while shares of the smaller Theravance surged 17.4 percent to $27.90 in afternoon trading on Nasdaq.

  • *FDA reviewers: Efficacy data not entirely consistent. Breo was developed by GlaxoSmithKline Plc, and Theravance Inc, whose shares jumped on Monday. GSK's shares rose 3.9 percent to 1,630 pence on the London Stock Exchange, while shares of the smaller Theravance surged 17.4 percent to $27.90 in afternoon trading on Nasdaq.

  • *CEO Levy sees improvement later this year in Europe. The group, which had in February warned that 2013 would be difficult in Europe, said it had been hit by a sharp advertising slowdown across the continent.

  • Wall Street Soars as Rest of Economy Limps Along Monday, 15 Apr 2013 | 11:20 AM ET

    The economy seems split in two, with the profits of the nation's largest companies and the stock market soaring as the rest of the economy continues to struggle.

  • April 15- Citigroup Inc said on Monday first-quarter profit jumped a better-than-expected 30 percent as the bank made more money from underwriting stock issues and advising companies on mergers. Citigroup shares rose 2.6 percent to $45.95 in morning trading.

  • *Adjusted EPS $1.29 vs Street view $1.17. April 15- Citigroup Inc reported a higher-than-expected 31 percent rise in first-quarter profit on Monday as it drew down loss reserves for mortgage loans, and revenue from its securities and investment banking business swelled. Citigroup shares were up 2 percent at $45.60 before the bell.

  • *Sprint shares up 14.5 pct premarket. April 15- Dish Network Corp, the No. 2 U.S. satellite television provider, offered to buy Sprint Nextel Corp for $25.5 billion in cash and stock, a move that could thwart the proposed acquisition of Sprint by Japan's SoftBank Corp..

  • UPDATE 1-Dish offers to buy Sprint for $25.5 bln Monday, 15 Apr 2013 | 7:04 AM ET

    *Sprint shares up 13 pct premarket. April 15- Dish Network Corp, the No. 2 U.S. satellite TV provider, offered to buy Sprint Nextel Corp for $25.5 billion in cash and stock, a move that could thwart the proposed acquisition of Sprint by Japan's SoftBank Corp..

  • Starbucks Bean Counters Cut Supermarket Prices Friday, 12 Apr 2013 | 11:30 AM ET

    Starbucks is cutting the suggested retail price of its bagged coffee sold in supermarkets, following similar moves by competitors amid falling commodity costs.

  • Wells Fargo: America's 'Boring Bank' Gets Makeover Friday, 12 Apr 2013 | 9:05 AM ET

    Wells Fargo executives have conceived a new vision for its branches—smaller to scale, but still full-service.

  • After KPMG Scandal, Who Will Audit Herbalife? Friday, 12 Apr 2013 | 9:00 AM ET

    Herbalife has already provided one of the best stock market dramas in years. Now, through no fault of its own, it could become a catalyst for change in the auditing profession. The NYT reports.

  • NEW YORK, April 12- JPMorgan Chase& Co posted higher first-quarter profit on Friday as it spent less money on litigation, but most of its major businesses turned in tepid performances, and the bank's overall revenue declined. JPMorgan's shares fell 1 percent to $48.80 in premarket trading.

  • JAB to Buy Douwe Egberts Firm for $10 Billion Friday, 12 Apr 2013 | 7:41 AM ET
    Douwe Egberts

    German investor Joh A Benckiser (JAB) is to buy the owner of Douwe Egberts coffee in a 7.5-billion-euro ($9.8 billion) deal to create a global hot drinks empire.

  • April 11- Rite Aid Corp posted its second consecutive quarterly profit on Thursday, as the third-largest U.S. drugstore chain filled more prescriptions and sold more generic drugs, which carry higher profit margins.

  • April 11- Rite Aid Corp posted its second consecutive quarterly profit on Thursday, as the third-largest U.S. drugstore chain filled more prescriptions and sold more generic drugs, which carry higher profit margins.